You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced thyroid cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Cancer Trial (20 mg Famitinib & 1200 mg Adebrelimab)

Not yet recruiting
  • Thyroid Cancer
  • 20 mg Famitinib & 1200 mg Adebrelimab
  • (no location specified)
Nov 26, 2023

Surgical Management of Advanced Thyroid Cancer

Recruiting
  • Thyroid Carcinoma
  • +6 more
  • Thyroidectomy with or without lymphadenectomy or multivisceral resection
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 31, 2023

Disease Burden, Genetic Heterogeneity and Tumour Evolution in

Recruiting
  • Thyroid Cancer
  • Sample collection only
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Apr 28, 2023

HRQOL in Locally Advanced Thyroid Carcinoma

Recruiting
  • Thyroid Cancer
  • +2 more
  • Tyrosine kinase inhibitor drugs.
  • Fuzhou, Fujian, China
    Road Fuma No.420
Apr 11, 2023

A Taiwanese Oncogenetic Panel and Integrated Clinical Data

Recruiting
  • Thyroid Cancer
  • A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients
  • Kaohsiung, Taiwan
  • +7 more
Sep 12, 2022

Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)

Recruiting
  • Differentiated Thyroid Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 9, 2023

Thyroid Cancer Stage IV, Radiation Toxicity Trial in Mumbai (Intensity Modulated Radiotherapy, Surgery alone)

Active, not recruiting
  • Thyroid Cancer Stage IV
  • Radiation Toxicity
  • Intensity Modulated Radiotherapy
  • Surgery alone
  • Mumbai, Maharashtra, India
    Gouri Pantvaidya
Apr 29, 2022

Anaplastic Thyroid Cancer, Relapsed/Refractory Poorly Differentiated Thyroid Cancer Trial in New York, Houston (AIC100 CAR T

Recruiting
  • Anaplastic Thyroid Cancer
  • Relapsed/Refractory Poorly Differentiated Thyroid Cancer
  • AIC100 CAR T Cells
  • New York, New York
    Weill Cornell Medical College
Feb 14, 2022

Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)

Active, not recruiting
  • Thyroid Cancer
  • +2 more
  • Stanford, California
    Stanford University
Nov 8, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

Not yet recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +3 more
  • Chang chun, Jilin, China
    Jinlin Province Cancer Hosipital
Dec 21, 2022

Thyroid Cancer Trial in Houston (Vemurafenib (All Groups), Vemurafenib (Post Surgery) - Group A + C, Post Surgery - Group B)

Active, not recruiting
  • Thyroid Cancer
  • Vemurafenib (All Groups)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 3, 2021

Locally Advanced or Metastatic Radioiodine-Refractory

Recruiting
  • Thyroid Neoplasms
  • Anlotinib Hydrochloride Capsule
  • Beijing, Beijing, China
  • +2 more
Aug 9, 2023

Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride

Not yet recruiting
  • Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
  • Anlotinib Hydrochloride Capsule and Penpulimab
  • Beijing, Beijing, China
    YansongLin
Sep 25, 2023

Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)

Not yet recruiting
  • Non-Medullary Thyroid Carcinoma
  • Digoxin tablet
  • (no location specified)
Aug 20, 2022

Differentiated Thyroid Cancer Trial in Spain (Cabozantinib)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Oviedo, Asturias, Spain
  • +9 more
Dec 14, 2022

Locally Advanced Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland

Not yet recruiting
  • Locally Advanced Thyroid Gland Anaplastic Carcinoma
  • +2 more
  • Chicago, Illinois
  • +1 more
Jul 7, 2022

Differentiated Thyroid Cancer Trial in Philadelphia (Everolimus, Sorafenib)

Active, not recruiting
  • Differentiated Thyroid Cancer
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Oct 18, 2021

Medullary Thyroid Cancer Trial in China (Anlotinib Hydrochloride Capsule)

Recruiting
  • Medullary Thyroid Cancer
  • Anlotinib Hydrochloride Capsule
  • Hefei, Anhui, China
  • +18 more
Apr 14, 2023

Differentiated Thyroid Cancer, Advanced Cancer Trial in Boston (LENVATINIB)

Recruiting
  • Differentiated Thyroid Cancer
  • Advanced Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Feb 3, 2022

Thyroid Cancer Trial in Palo Alto (Pembrolizumab (Keytruda))

Recruiting
  • Thyroid Cancer
  • Pembrolizumab (Keytruda)
  • Palo Alto, California
    Stanford University
Feb 16, 2022

Thyroid Cancer Trial in Shanghai (Anlotinib, surgery, core needle biopsy)

Active, not recruiting
  • Thyroid Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 30, 2021

Advanced Solid Tumor Trial (HEC169096)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Jul 6, 2022

Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • CNSI-Fe(II) 30 mg
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Sep 15, 2023

Thyroid Cancer Trial in Worldwide (Irofulven + capecitabine)

Completed
  • Thyroid Cancer
  • Irofulven + capecitabine
  • Aurora, Colorado
  • +9 more
Jun 11, 2021

Thyroid Cancer Trial in Peking (Apatinib)

Completed
  • Thyroid Cancer
  • Peking, China
    Peking Union Medical College Hospital
Jan 18, 2022